arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Q32 Bio Inc.

QTTB Health Care Biotechnology: Pharmaceutical Preparations
$8.65
▼ -0.2% Today
as of Oct 23, 16:51 ET
Last 30 days -20.71% Sep 14 → Oct 23
$7.23 $8.29 $9.35 $10.40 $11.46 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$8.80
High
$8.83
Low
$8.30
Volume
$403,793
Avg Vol
$1M
Mkt Cap
$246M
P/E (TTM)
—
Beta
—
52w High
$23.57
52w Low
$1.91
Div Yield
—
Shares Out
$24M

Recent Press Releases & News last 60 days · 6 items

Sep 30 · 13:15 PR PR Newswire
Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026
Sep 28 · 10:43 MT Newswires
Jefferies Initiates Q32 Bio at Buy With $29 Price Target
Sep 21 · 13:15 PR PR Newswire
Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Congress 2026
▸ Show all 6 press releases & news Free account →

QTTB earnings at a glance

The options market is pricing a move of about ±50.1% after the report, a range of roughly $4.32 to $12.98 from today's $8.65. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±1.9% on average; after the most recent report on May 5, 2026 it moved +2.0%. That means options currently expect more movement than QTTB has typically delivered. QTTB beat the consensus EPS estimate in 2 of its last 3 reported quarters. Implied volatility is currently 424%. The share price of $8.65 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.91
$24
31% of range
Avg surprise (last 3)
+28.2%
Avg reaction (last 2)
+0.0%
50% positive
Latest IV / EM
424%
EM ±50.1% · $8 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-40.52$-30.50$-20.48$-10.46$-0.44 Actual $-19.84Actual $-16.69Actual $-40.52Actual $-6.33Actual $-1.42Actual $-1.46Actual $-0.90Actual $-0.78Est $-1.14Actual $-0.60Est $-1.39Actual $-0.54Est $-0.52Actual $-0.44 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-18M$-15M$-13M$-10M$-8M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.44 — — — — financials
Tue May 5, 2026Mar/2026 $-0.54 $-0.52 -3.9% +40.0% +2.0% earnings
Thu Nov 13, 2025Sep/2025 $-0.60 $-1.39 +56.8% — — earnings
Wed Aug 6, 2025Jun/2025 $-0.78 $-1.14 +31.6% — — earnings
Thu May 8, 2025Mar/2025 $-0.90 — — — -1.9% earnings
Mon Sep 30, 2024Sep 2024 $-1.46 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.42 — — — — financials
Sun Mar 31, 2024Mar 2024 $-6.33 — — — — financials
Sat Sep 30, 2023Sep 2023 $-40.52 — — — — financials
Fri Jun 30, 2023Jun 2023 $-16.69 — — — — financials
Fri Mar 31, 2023Mar 2023 $-19.84 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue———————$0
Cost of revenue————————
Gross profit————————
Operating income$-9M$-8M—$-8M$-9M$-12M—$-19M
Net income$-9M$-8M—$-7M$-9M$-11M—$-18M
EPS (diluted)$-0.44$-0.54—$-0.60$-0.78$-0.90—$-1.46

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$106M$51M$48M$49M$55M$65M$78M$89M
Inventory————————
Total current assets$110M$57M$55M$51M$58M$69M$82M$94M
Total assets$116M$64M$62M$58M$66M$79M$92M$105M
Long-term debt————————
Total liabilities$10M$17M$20M$76M$78M$83M$87M$86M
Total equity$106M$46M$42M$-18M$-12M$-4M$6M$18M

Implied volatility — last 90 days

73%249%426%602%778% Jun 25 — IV 243% · EM ±47.5%Jun 29 — IV 199% · EM ±35.2%Jun 30 — IV 211% · EM ±36.3%Jul 01 — IV 169% · EM ±28.2%Jul 02 — IV 181% · EM ±29.2%Jul 03 — IV 187% · EM ±29.2%Jul 06 — IV 143% · EM ±19.8%Jul 08 — IV 306% · EM ±38.4%Jul 09 — IV 336% · EM ±39.7%Jul 10 — IV 456% · EM ±50.4%Jul 13 — IV 197% · EM ±16.5%Jul 14 — IV 186% · EM ±13.5%Jul 15 — IV 254% · EM ±15.0%Jul 16 — IV 178% · EM ±7.5%Jul 20 — IV 130% · EM ±30.8%Jul 21 — IV 116% · EM ±27.0%Jul 22 — IV 109% · EM ±25.0%Jul 23 — IV 99% · EM ±22.2%Jul 24 — IV 113% · EM ±24.9%Jul 27 — IV 80% · EM ±16.8%Jul 28 — IV 90% · EM ±18.5%Jul 29 — IV 112% · EM ±22.4%Jul 30 — IV 99% · EM ±19.4%Jul 31 — IV 108% · EM ±20.6%Aug 03 — IV 100% · EM ±17.8%Aug 04 — IV 124% · EM ±21.4%Aug 05 — IV 134% · EM ±22.4%Aug 06 — IV 112% · EM ±18.1%Aug 07 — IV 107% · EM ±16.7%Aug 10 — IV 101% · EM ±14.0%Aug 11 — IV 148% · EM ±19.6%Aug 12 — IV 119% · EM ±15.0%Aug 13 — IV 95% · EM ±11.2%Aug 14 — IV 76% · EM ±8.4%Aug 17 — IV 191% · EM ±16.0%Aug 18 — IV 104% · EM ±7.5%Aug 19 — IV 209% · EM ±12.3%Aug 20 — IV 370% · EM ±15.4%Aug 24 — IV 124% · EM ±25.8%Aug 25 — IV 121% · EM ±24.8%Aug 26 — IV 90% · EM ±18.1%Aug 27 — IV 90% · EM ±17.6%Aug 28 — IV 124% · EM ±23.8%Aug 31 — IV 86% · EM ±15.3%Sep 01 — IV 130% · EM ±22.5%Sep 02 — IV 148% · EM ±24.7%Sep 03 — IV 75% · EM ±12.1%Sep 04 — IV 111% · EM ±17.3%Sep 07 — IV 125% · EM ±17.3%Sep 08 — IV 128% · EM ±16.9%Sep 09 — IV 414% · EM ±51.8%Sep 10 — IV 138% · EM ±16.3%Sep 11 — IV 188% · EM ±20.7%Sep 14 — IV 208% · EM ±17.4%Sep 15 — IV 526% · EM ±38.0%Sep 16 — IV 779% · EM ±46.0%Sep 17 — IV 375% · EM ±15.7%Sep 21 — IV 81% · EM ±17.0%Sep 22 — IV 83% · EM ±17.0%Sep 23 — IV 104% · EM ±20.9%Sep 24 — IV 73% · EM ±14.4%Sep 25 — IV 198% · EM ±38.0%Sep 28 — IV 101% · EM ±18.0%Sep 29 — IV 96% · EM ±16.5%Sep 30 — IV 165% · EM ±27.5%Oct 01 — IV 174% · EM ±28.2%Oct 02 — IV 162% · EM ±25.4%Oct 06 — IV 406% · EM ±53.6%Oct 07 — IV 215% · EM ±26.9%Oct 08 — IV 424% · EM ±50.1%

Sector peers

AKBA
Akebia Therapeutics, Inc.
$241M $0.57-3.1%
IFRX
InflaRx N.V.
$252M $1.56+0.7%
SLGL
Sol-Gel Technologies Ltd.
$238M $69.45+5.7%
AMRN
Amarin Corporation plc
$254M $11.79+2.4%
SIGA
SIGA Technologies Inc.
$234M $3.120.0%
BCYC
Bicycle Therapeutics plc
$261M $3.55-0.6%

QTTB earnings FAQ

What is QTTB's expected move for earnings?

Options currently price a move of about ±50.1%, or $4.33 per share either way from $8.65.

How does QTTB stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.9%, up 1 times and down 1 times.

What is QTTB's implied volatility?

QTTB's at-the-money implied volatility is about 424% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in